Cardiac rhythm management devices (part II): Perioperative management

Anesthesiology

Volumn 95, Issue 6, 2001, Pages 1492-1506

  Atlee, John L ^a,e   Bernstein, Alan D ^b,c,d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c Department of Surgery

^d NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^e FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CATECHOLAMINE; ENCAINIDE; FLECAINIDE; GLUCOCORTICOID; LIDOCAINE; MORACIZINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ARTIFACT; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; CAUTERIZATION; DEVICE; DRUG EFFECT; EVALUATION; HEART ARRHYTHMIA; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; LITHOTRIPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SENSOR; TACHYCARDIA; TREATMENT FAILURE;

EID: 0035205680     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200112000-00032     Document Type: Review

References (94)

1. The NASPE/BPEG generic pacemaker code for antibrady-arrhythmia and adaptive-rate pacing and antitachyarrhythmia devices
2. The frequency of pacemaker-system problems, etiologies, and corrective interventions
3. Pacemaker diagnostics and evaluation of pacing system malfunction
4. Cardiac pacemakers
5. Power systems for implantable pacemakers, cardioverters, and defibrillators
6. Myocardial stimulation threshold in patients with cardiac pacemakers: Effect of physiologic variables, pharmacologic agents, and lead electrodes
7. Effect of changes in potassium and calcium concentrations on diastolic threshold and strength-interval relationships of the human heart
8. Effects of acid-base imbalance on myocardial pacing thresholds
9. Transvenous pacemaker failure induced by hyperkalemia
10. Alteration of pacemaker threshold by drug and physiological factors
11. Exit block in myxedema, treated effectively by thyroid hormone therapy
12. Physiological changes in threshold
13. Increased pacing threshold after an automatic defibrillator shock in dogs: Effects of class I and class II antiarrhythmic drugs
14. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds
15. Effects of antiarrhythmic drugs on the chronic pacing threshold and the endocardial R wave amplitude in the conscious dog
16. Failure to pace following high dose antiarrhythmic therapy: Reversal with isoproterenol
17. Acute effects of anti-arrhythmic drugs on cardiac pacing threshold
18. Propafenone induced acute variation of chronic atrial pacing threshold: A case report
19. Effects of encainide on the function of implanted pacemakers
20. Effect of enflurane, isoflurane, and halothane on pacing stimulation thresholds in man
21. Surgical electrocautery and the runaway pacemaker syndrome
22. Runaway pacemaker: A still existing complication and therapeutic guidelines
23. Far-field QRS complex sensing via the atrial pacemaker lead, I: Mechanism, consequences, differential diagnosis and countermeasures in AAI and VDD/DDD pacing
24. Electrical proarrhythmia: Induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator
25. Pacemaker failure on induction of anaesthesia
26. Cross-talk in bipolar pacemakers
27. Crosstalk with external bipolar DVI pacing: A case report
28. Crosstalk during bipolar pacing
29. Rate-adaptive cardiac pacing: Implications of environmental noise during craniotomy
30. An unexpected rate response of a minute ventilation dependent pacemaker (letter)
31. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes
32. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers
33. Electromagnetic interference with implantable devices
34. Effect of 15 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers
35. Improved efficacy of mode switching during atrial fibrillation using automatic atrial sensitivity adjustment
36. Effect of varying atrial sensitivity, AV interval, and detection algorithm on automatic mode switching
37. Reliability of a new algorithm for automatic mode switching from DDDR to DDIR pacing mode in sinus node disease patients with chronotropic incompetence and recurrent paroxysmal atrial fibrillation
38. Timing cycles and operational characteristics of pacemakers
39. Atrio-ventricular and ventriculo-atrial conduction times in patients undergoing pacemaker implant
40. Prevalence and significance of ventriculoatrial conduction
41. Prevalence of retrograde conduction in heart block after DDD pacemaker implantation
42. Approach to generator change
43. Follow-up of the paced patient
44. Cardiac pacemakers and antiarrhythmic devices
45. The implantable cardioverter defibrillator
46. Evaluation of implantable cardioverter-defibrillator malfunction, diagnostics, and programmers
47. Anesthesia and the automatic implantable cardioverter/defibrillator
48. Limitations and late complications of third-generation automatic cardioverter-defibrillators
49. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator
50. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators: Prospective comparison of different lead system-device combinations
51. Influence of anaesthesia on defibrillation threshold
52. Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy
53. Interactions between implantable cardioverter-defibrillators and class III agents
54. Multiple inappropriate shocks precipitated by interrogation of an implantable cardioverter defibrillator
55. Implantable cardioverter defibrillators
56. The effect of 50 Hz external electrical interference on implanted cardiac pacemakers
57. Electrocautery-induced reprogramming of a pacemaker using a precordial magnet
58. Aborted implantable cardioverter defibrillator shock during facial electrosurgery
59. Interaction between permanent cardiac pacing and electrocautery: The significance of electrode position
60. Upper limit ventricular stimulation in respiratory rate responsive pacing due to electrocautery
61. Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems
62. Clinical interactions between pacemakers and automatic implantable cardioverter defibrillators
63. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system
64. Pacemaker malfunction
65. Magnetic resonance imaging in a patient with a dual-chamber pacemaker
66. Effects of nuclear magnetic resonance imaging on cardiac pacemakers
67. Management of radiation oncology patients with implanted cardiac pacemakers: Report of AAPM Task Group No. 34
68. Radiation-induced effects in multiprogrammable pacemakers and implantable defibrillators
69. Pacemaker failure induced by radiotherapy
70. Runaway pacemaker during high-energy neutron radiation therapy
71. Interference in cardiac pacemakers
72. Rate-responsive pacemakers and anaesthesia: A consideration of possible implications
73. Pacemaker-induced tachycardia during general anaesthesia: A case report
74. Pacemaker malfunction associated with positive-pressure ventilation
75. Cardiac pacemaker inhibition by transcutaneous electrical nerve stimulation
76. Can transcutaneous electrical nerve stimulation be safely used in patients with permanent cardiac pacemakers?
77. Pacemaker-mediated tachycardia induced by intraoperative somatosensory evoked potential stimuli
78. Acute effects of radiofrequency ablation of atrial arrhythmias on implanted permanent pacing systems
79. Pacemaker function during radiofrequency ablation
80. Pacemaker and implantable cardioverter-defibrillator radiography
81. Use of an ultrasonic scalpel as an alternative to electrocautery in patients with pacemakers
82. Permanent pacemaker and implantable cardioverter-defibrillator implantation
83. NASPE expert consensus document: Use of i.v. (conscious) sedation/analgesia by nonanesthesia personnel in patients undergoing arrhythmia specific diagnostic, therapeutic, and surgical procedures
84. Conscious sedation and implantable devices: Safe and effective sedation during pacemaker and implantable cardioverter defibrillator placement
85. Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory
86. Subcutaneous single-incision implantation of cardioverter-defibrillators under local anesthesia by electrophysiologists in the electrophysiology laboratory
87. Implantation of the automatic implantable cardioverter defibrillator (AICD): Practical aspects
88. Perioperative management of the patient undergoing automatic internal cardioverter-defibrillator implantation
89. Awareness during anaesthesia for implantable cardioverter defibrillator implantation: Recall of defibrillation shocks
90. Testing of implantable defibrillator functions at implantation
91. Mechanisms for cardiac dysrhythmias during anesthesia
92. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction
93. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction
94. Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction